BRIEF published on 05/30/2024 at 07:35, 5 months 22 days ago Ikonisys Launches New Website to Promote FISH Technology and Total Automation in Healthcare Automation Healthcare Ikonisys FISH Technology Mass Screening
PRESS RELEASE published on 05/30/2024 at 07:30, 5 months 22 days ago Inside Information / Other news releases Ikonisys launches new website focusing on FISH technology and total automation in healthcare, enhancing mass cancer screening with advanced solutions and seamless integration Healthcare Ikonisys FISH Technology Mass Screening Total Automation
BRIEF published on 05/15/2024 at 07:35, 6 months 6 days ago Ikonisys: New international patent for Hospitex Ikonisys BLOCKfast Hospitalex International International Patent Cancer Diagnosis
PRESS RELEASE published on 05/15/2024 at 07:30, 6 months 6 days ago Inside Information / Other news releases Hospitex International obtains international patent for BLOCKfast cyto-inclusion kit, enhancing global cancer diagnosis solutions. Company offers innovative diagnostics solutions in cytology Hospitex International BLOCKfast Cyto-inclusion Kit Global Commercial Development Cancer Diagnosis Solutions Cytology Diagnostics
PRESS RELEASE published on 02/06/2024 at 10:11, 9 months 15 days ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy Ikonisys SA receives Buy recommendation and increased price target to EUR 6.30 from EUR 4.50 per share after acquiring Hospitex, an Italian-based cytology company Acquisition Strategic Partnership Ikonisys SA Hospitex Cancer Diagnostics
PRESS RELEASE published on 11/01/2023 at 11:26, 1 year ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy
PRESS RELEASE published on 07/31/2023 at 07:56, 1 year 3 months ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy
PRESS RELEASE published on 05/08/2023 at 08:37, 1 year 6 months ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy
Published on 11/21/2024 at 13:30, 30 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 30 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 25 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 45 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 2 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 40 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 15 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 15 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
